Zeynep Gulsum Guc
Overview
Explore the profile of Zeynep Gulsum Guc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
On S, Koksal B, Arik Z, Caner B, Ercan Uzundal D, Yazici O, et al.
Curr Oncol
. 2024 Nov;
31(11):6803-6813.
PMID: 39590133
(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines. This study was designed...
2.
Aksu A, Guc Z, Kucuker K, Alacacioglu A, Turgut B
Rev Esp Med Nucl Imagen Mol (Engl Ed)
. 2024 Mar;
43(3):500002.
PMID: 38527731
Objective: The aim of our study was to evaluate the contribution of 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) radiomic data obtained from both the tumoral and peritumoral area in predicting...
3.
Gultekin S, Cakir A, Guc Z, Ozalp F, Keskinkilic M, Yavuzsen T, et al.
Support Care Cancer
. 2024 Jan;
32(2):119.
PMID: 38252310
Purpose: The primary purpose of this study was to evaluate functional status and health-related parameters in ovarian cancer (OC) survivors and to compare these parameters with healthy controls. The secondary...
4.
Bilici A, Koca S, Karaagac M, Goktas Aydin S, Eraslan E, Kaplan M, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(11):8243-8253.
PMID: 37067546
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients And Methods: This multicenter study is based on retrospective...
5.
Subasioglu A, Guc Z, Gur E, Tekindal M, Atahan M
Eur J Breast Health
. 2023 Jan;
19(1):55-69.
PMID: 36605468
Objective: The aim of this study was to determine the frequency of germline variants in and in patients admitted to a medical genetics clinic with breast cancer and to assess...
6.
Guc Z, Guc H, Butun O, Alacacioglu A, Demirdover C
J Plast Reconstr Aesthet Surg
. 2023 Jan;
77:244-252.
PMID: 36592535
Background: Dermatofibrosarcoma protuberans (DFSP) is a slow-growing, low- to intermediate-grade malignant sarcoma. Its optimal treatment is resection with wide margins; the likelihood of local control associated with this procedure exceeds...
7.
Guc Z, Alacacioglu A, Kalender M, Oflazoglu U, Unal S, Yildiz Y, et al.
Front Nutr
. 2022 Sep;
9:905292.
PMID: 36061883
Objective: The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and the Geriatric Nutrition Risk Index (GNRI) are used as prognostic factors in different types of cancers. In this study we...
8.
Guc Z, Altay C, Ozgul H, Ellidokuz H, Yavuzsen T
Support Care Cancer
. 2022 Jun;
30(10):7845-7852.
PMID: 35716261
Objective: To evaluate the correlation between sarcopenia and inflammation- and nutrition-based markers in metastatic colorectal cancer (mCRC) patients. Materials And Methods: Age, body mass index (BMI), neutrophil/lymphocyte ratio (NLR), modified...
9.
Oflazoglu U, Caglar S, Yilmaz H, Onal H, Varol U, Salman T, et al.
Eur Geriatr Med
. 2022 Mar;
13(4):795-803.
PMID: 35277853
Aim: Sarcopenia is a progressive and generalized syndrome that can be linked to many causes such as cancers, and is caused by a quantitative and qualitative disorder (loss of muscle...
10.
Guc Z, Turgut B, Avci A, Cengiz F, Kalender M, Alacacioglu A
Nucl Med Commun
. 2022 Jan;
43(5):560-567.
PMID: 35045553
Background: Gastric cancer is the second leading cause of cancer-related deaths, with a 5-year survival rate of about 20-25%. The ability to predict pathological response (PR) to neoadjuvant chemotherapy (NACT);...